In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
Daniel Roeska, Bernstein U.S. automotive research, joins 'Power Lunch' to discuss whether Rivian can catch up to Tesla in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback